Stock 6062 CHARM CARE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Charm Care Corporation

Equities

6062

JP3512740006

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-06-07 am EDT 		5-day change 1st Jan Change
1,569 JPY +1.36% Intraday chart for Charm Care Corporation +1.49% +23.84%
Feb. 06 Charm Care Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024 CI
2023 Charm Care Corporation Provides Year End Dividend Guidance for the Year Ending June 30, 2024 CI

Valuation

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Capitalization 1 39,652 31,214 42,222 51,241 - -
Enterprise Value (EV) 1 42,021 35,151 48,568 51,241 51,241 51,241
P/E ratio 25.8 x 10.6 x 13.2 x 12.8 x 11.1 x 11.9 x
Yield 0.99% 1.78% 1.7% 1.66% 1.91% 1.91%
Capitalization / Revenue 1.73 x 1.07 x 1.11 x 1.09 x 1.09 x 0.94 x
EV / Revenue 1.73 x 1.07 x 1.11 x 1.09 x 1.09 x 0.94 x
EV / EBITDA - 10.7 x 8.36 x 8.31 x 7.52 x 6.64 x
EV / FCF - - -24,476,762 x - - -
FCF Yield - - -0% - - -
Price to Book 3.58 x 2.52 x 2.8 x 2.79 x 2.32 x 2.02 x
Nbr of stocks (in thousands) 32,608 32,617 32,629 32,658 - -
Reference price 2 1,216 957.0 1,294 1,569 1,569 1,569
Announcement Date 8/6/21 8/8/22 8/7/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Net sales 1 22,984 29,071 37,887 47,000 47,200 54,600
EBITDA 1 - 2,914 5,053 6,164 6,814 7,714
EBIT 1 2,015 2,309 4,197 5,200 5,800 6,700
Operating Margin 8.77% 7.94% 11.08% 11.06% 12.29% 12.27%
Earnings before Tax (EBT) 1 2,293 4,536 4,864 6,500 7,100 6,700
Net income 1 1,535 2,951 3,206 4,000 4,600 4,300
Net margin 6.68% 10.15% 8.46% 8.51% 9.75% 7.88%
EPS 2 47.09 90.50 98.28 122.5 140.9 131.7
Free Cash Flow - - -1,725 - - -
FCF margin - - -4.55% - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 12.00 17.00 22.00 26.00 30.00 30.00
Announcement Date 8/6/21 8/8/22 8/7/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 11,365 6,525 12,511 9,097 7,463 7,352 7,499 14,851 7,635 15,401 23,036 10,011 18,587 10,997 17,417 28,414 9,550 9,820 9,930 17,900
EBITDA - - - - - - - - - - - - - - - - - - - -
EBIT 1 1,115 488 889 927 493 491 446 937 431 2,829 3,260 693 1,570 908 2,723 3,631 970 1,080 1,190 2,560
Operating Margin 9.81% 7.48% 7.11% 10.19% 6.61% 6.68% 5.95% 6.31% 5.65% 18.37% 14.15% 6.92% 8.45% 8.26% 15.63% 12.78% 10.16% 11% 11.98% 14.3%
Earnings before Tax (EBT) 1,237 - 880 2,665 - 560 - 1,179 598 - - 715 1,755 1,108 - - - - - -
Net income 1 796 291 553 1,742 656 362 395 757 382 2,067 2,449 460 1,136 723 2,141 2,864 630 770 800 2,400
Net margin 7% 4.46% 4.42% 19.15% 8.79% 4.92% 5.27% 5.1% 5% 13.42% 10.63% 4.59% 6.11% 6.57% 12.29% 10.08% 6.6% 7.84% 8.06% 13.41%
EPS 24.43 - 16.98 53.40 - 11.12 - 23.23 11.70 - - 14.10 34.81 22.14 - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/5/21 2/7/22 2/7/22 5/9/22 8/8/22 11/7/22 2/3/23 2/3/23 5/8/23 8/7/23 8/7/23 11/6/23 2/5/24 5/7/24 - - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Net Debt 2,369 3,937 6,346 - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - 1.351 x 1.256 x - - -
Free Cash Flow - - -1,725 - - -
ROE (net income / shareholders' equity) 13.9% 25.1% 23.3% 23.9% 22.7% 18.1%
ROA (Net income/ Total Assets) - 7.58% 11.5% 10.7% 10.3% 11%
Assets 1 - 38,909 27,908 37,383 44,660 39,091
Book Value Per Share 2 340.0 380.0 462.0 562.0 677.0 778.0
Cash Flow per Share 61.70 109.0 118.0 - - -
Capex 1 2,983 2,730 2,221 2,800 3,000 3,200
Capex / Sales 12.98% 9.39% 5.86% 5.96% 6.36% 5.86%
Announcement Date 8/6/21 8/8/22 8/7/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Charm Care Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CHARM CARE CORPORATION Stock Charm Care Corporation
+23.84% 327M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+24.66% 88.38B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-21.76% 77.56B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+8.45% 26.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+7.94% 18.45B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.50% 16.57B
NATERA, INC. Stock Natera, Inc.
+77.51% 13.65B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+76.96% 13.06B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.72% 12.61B
DAVITA INC. Stock DaVita Inc.
+36.67% 12.56B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 6062 Stock
  4. Financials Charm Care Corporation